Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

16.70
Delayed Data
As of Jun 23
 +0.20 / +1.21%
Today’s Change
7.75
Today|||52-Week Range
32.20
+26.04%
Year-to-Date

Today’s Trading

Previous close16.50
Today’s open16.45
Day’s range16.10 - 16.85
Volume4,468,183
Average volume (3 months)2,229,948
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-44.12%
Earnings growth (next 5 years)+9.80%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...+0.66+0.81%
TXMDTherapeuticsMD Inc-0.02-0.35%
GBTGlobal Blood Therape...+0.60+2.05%
DERMDermira Inc+0.80+2.60%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts